市場調査レポート
商品コード
1157274

栄養補助食品成分の世界市場:種類別 (プロバイオティクス、タンパク質、アミノ酸、ファイトケミカル・植物エキス、繊維質・特殊炭水化物))・用途別 (食品、飲料、動物栄養、栄養補助食品・形状別・地域別の将来予測 (2027年まで)

Nutraceutical Ingredients Market by Type (Probiotics, Proteins, Amino Acids, Phytochemicals & Plant Extracts, Fibers & Specialty Carbohydrates), Application (Food, Beverages, Animal Nutrition, Dietary Supplements), Form & Region -Global Forecast -2027

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 354 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
栄養補助食品成分の世界市場:種類別 (プロバイオティクス、タンパク質、アミノ酸、ファイトケミカル・植物エキス、繊維質・特殊炭水化物))・用途別 (食品、飲料、動物栄養、栄養補助食品・形状別・地域別の将来予測 (2027年まで)
出版日: 2022年11月11日
発行: MarketsandMarkets
ページ情報: 英文 354 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の栄養補助食品成分の市場規模は今後、7.2%でのCAGRで成長し、2022年に1,852億米ドル、2027年には2,617億米ドルに達すると予測されます。

ここ数年、人々の健康やホリスティック・ウェルネスに対する意識は高まっています。国民の大半は、ペースの速いライフスタイルに影響され、人々は代替の栄養を探し始めたので、栄養補助食品成分市場の上昇をもたらしました。

"種類別では、プロバイオティクス栄養補助食品が予測期間に最大の市場シェア (金額ベース) を有する"

技術改良の進展や科学の進歩は、過去20年間でプロバイオティクス業界を成長させました。近年のプロバイオティクス人気やその健康上の利点が、今後の栄養補助食品成分の市場成長を促進すると推定されます。

"用途別では、食品セグメントが最大の市場シェアを占める"

消費者の健康志向や意識が高まるにつれ、バランスの取れた食事や健康的な食品への嗜好が高く保たれています。そして、このことを考慮し、食品メーカーは健康的な代替品となり得る製品の革新を開始しました。それが、栄養補助食品成分市場においてより高い市場シェアの獲得につながっていると考えられています。

"形状別では、乾燥成分が予測期間中に最速の市場成長を達成する"

乾燥状の栄養補助食品成分はその活用領域が液体状よりも広く、それが高い市場シェアの主要な要因となっています。栄養補助食品製品のほとんどが、乾燥状態の成分を使用しています。乾燥成分は、液状のものに比べて安定性が高く、保存期間も長くなります。したがって、乾燥食品は急速に成長すると予測されます。

当レポートでは、世界の栄養補助食品成分の市場について分析し、市場の基本構造や最新情勢、主な市場促進・抑制要因、健康効果別・種類別・形状別・用途別・地域別の市場動向の見通し、市場競争の状態、主要企業のプロファイルなどを調査しております。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • マクロ経済指標
    • 世界各地での肥満症の有病率の高さ
    • 主要データ
  • 市場力学

第6章 産業動向

  • イントロダクション
  • バリューチェーン分析
    • 原材料の調達
    • 製造
    • 流通・マーケティング・販売
  • 顧客のビジネスに影響を与える動向/混乱
  • 技術分析
    • 食品のマイクロカプセル化
    • 革新的・破壊的な技術
  • 価格分析
  • 特許分析
  • 市場マップ
    • 上流工程
    • 下流工程
  • 貿易シナリオ
  • 主な会議とイベント (2022年~2023年)
  • 貿易と規制の状況
  • ポーターのファイブフォース分析
  • 主な利害関係者と購入基準
  • ケーススタディ分析

第7章 栄養補助食品成分市場:健康効果別

  • イントロダクション
  • 認知機能の健康
  • 腸の健康
  • 心臓の健康
  • 骨の健康
  • 免疫
  • 栄養
  • 体重管理
  • その他

第8章 栄養補助食品成分市場:種類別

  • イントロダクション
  • プロバイオティクス
  • タンパク質・アミノ酸
  • ファイトケミカル (植物化学物質)・植物エキス
  • 繊維質・特殊炭水化物
  • オメガ3脂肪酸
  • ビタミン
  • プレバイオティクス
  • カロテノイド
  • ミネラル
  • その他の種類

第9章 栄養補助食品成分市場:形状別

  • イントロダクション
  • 乾燥
  • 液体

第10章 栄養補助食品成分市場:用途別

  • イントロダクション
  • 食品
    • スナック食品
    • 菓子類
    • ベーカリー
    • 乳製品
    • 食肉・肉製品
    • ベビーフード
    • その他
  • 飲料
    • エネルギードリンク
    • ジュース
    • 健康飲料
  • パーソナルケア用品
  • 動物栄養
  • 栄養補助食品

第11章 栄養補助食品成分市場:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • 他の欧州諸国
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア・ニュージーランド
    • 他のアジア太平洋諸国
  • 南米
    • ブラジル
    • アルゼンチン
    • 他の南米諸国
  • 他の国々 (RoW)
    • 中東
    • アフリカ

第12章 競合情勢

  • 概要
  • 市場シェア分析 (2021年)
  • 主要企業の収益分析:セグメント別
  • 主要企業が採用した戦略
  • 企業評価クアドラント(主要企業)
  • 栄養補助食品成分市場:新興企業/中小企業向けの評価クアドラント (2021年)
  • 製品の発売・資本取引・その他の動向

第13章 企業プロファイル

  • イントロダクション
  • 主要企業
    • ASSOCIATED BRITISH FOODS PLC
    • ARLA FOODS AMBA
    • DSM
    • INGREDION
    • TATE & LYLE
    • AJINOMOTO CO., INC.
    • CHR HANSEN HOLDING A/S.
    • KYOWA HAKKO BIO CO., LTD.
    • GLANBIA PLC
    • FONTERRA CO-OPERATIVE GROUP LIMITED
    • CARGILL INCORPORATED
    • ADM
    • INTERNATIONAL FLAVORS & FRAGRANCES INC.
    • BASF SE
    • KERRY GROUP PLC
  • その他の企業
    • BALCHEM INC.
    • SYDLER INDIA PVT. LTD.
    • PROBI
    • DIVI'S LABORATORIES LIMITED
    • MARTIN BAUER
    • BENEO GMBH
    • NEXIRA
    • ROQUETTE FRERES
    • CONAGEN, INC.
    • NUTRACEUTICALS GROUPS

第14章 隣接・関連市場

  • イントロダクション
  • 制限事項
  • 機能性食品成分市場
  • 栄養補助食品賦形剤市場

第15章 付録

目次
Product Code: FB 2211

The market for nutraceutical ingredients is estimated at USD 185.2 Billion in 2022; it is projected to grow at a CAGR of 7.2% to reach USD 261.7 Billion by 2027. Nutraceutical ingredients are substances that are used to improve health, prevent chronic diseases, increase life expectancy, slow the aging process, or support the body's systems. Nutraceutical ingredients are viewed as more of a preventive measure than a cure. Because these ingredients work on specific problems, they are frequently used as an ingredient in the formulation of products. Industries like food, beverage, dietary supplement, animal nutrition, and personal care are some of the most applied in their product formulation. These products are becoming more popular in the market due to their nutritional benefits and compatibility with people's lifestyles. Immunity boosters, bone & health, cardiovascular health, mental wellness, infant nutrition, weight loss management, and other nutraceutical products are currently popular. People's awareness of health and holistic wellness has grown over the last few years. The fast-paced lifestyle of the majority of the population influenced the rise in the nutraceutical ingredient market as people began looking for alternative's nutrition.

The probiotics nutraceutical product by type is projected to have the highest market share in terms of value in nutraceutical ingredient market throughout the forecast period.

The increasing technology improvements and scientific advancement have made the probiotic industry grow over the last two decades. Probiotic strains are considered to be difficult and expensive to manufacture, as these strains need special environment & medium to grow, temperature, and can take longer time to cultivate and cannot speed up the cultivation process. And recent popularity for probiotics, and its several health benefits, their market is estimated to observe growth in nutraceutical ingredient market in the near future.

The Food segments by application is projected to have the highest market share in the global nutraceutical ingredient market.

Major companies have extensively invested on product development and innovation of nutraceutical food products. The companies have been targeting customers and understanding their needs to find better food solutions. As consumers are becoming health conscious and aware, the preference for balanced diets and healthy food has remained high. And because of their palatability, mouth feel and texture. Considering this, food producers started innovating products which can be healthy alternative. Hence, their market is estimated to gain more market share in the nutraceutical ingredient market.

The dry ingredient, by form is projected to attain the fastest market growth in the nutraceutical ingredients market throughout the forecasted period

The wide application of dry form of nutraceutical ingredients have been the key factor in its high market share as compared to liquid form. Most of the nutraceutical food product formulation uses dry form of ingredient, which also depends on the product formulation. Dry ingredients are more stable, have extended shelf life as compared to those of liquid form. Hence, dry form of ingredient projected to attain fast market growth.

Break-up of Primaries

  • By Company type: Tier 1: 25%, Tier 2: 35%, Tier 3: 40%
  • By Designation: Director level: 30%, C-level: 25%, and Manager level : 45%
  • By Region: Europe: 28%, Asia Pacific: 33%, North America: 17%, RoW: 22%

Leading players profiled in this report

  • Associated British Foods Plc (UK)
  • Arla Foods Ingredients Group P/S (Denmark)
  • DSM (Netherland)
  • Ingredion (US)
  • Tate & Lyle (UK)
  • Ajinomoto Co., Inc. (Japan)
  • CHR Hansen Holdings A/S. (Denmark)
  • Kyowa Hakko Bio Co., Ltd. (Japan)
  • Glanbia Plc (Ireland)
  • Fonterra Co. Operative Group Limited (New Zealand)
  • Cargill Incorporated (US)
  • ADM (US)
  • International Flavors & Fragrances, Inc. (US)
  • BASF SE (Germany)
  • Kerry Groups (Ireland)

Research Coverage

This report segments the nutraceutical ingredients market on the basis of type of ingredient, application, health benefits and region. In terms of insights, this research report focuses on various levels of analyses-competitive landscape, end-use analysis, and company profiles-which together comprise and discuss the basic views on the emerging & high-growth segments of the nutraceutical ingredients market, the high-growth regions, countries, government initiatives, market disruption, drivers, restraints, opportunities, and challenges.

Reasons to buy this report

  • To get a comprehensive overview of the nutraceutical ingredients market
  • To gain wide-ranging information about the top players in this industry, their product portfolios, and key strategies adopted by them
  • To gain insights about the major countries/regions, in which the nutraceutical ingredients market is flourishing.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED
    • FIGURE 1 NUTRACEUTICAL INGREDIENTS MARKET SNAPSHOT
    • 1.3.2 GEOGRAPHIC SEGMENTATION
    • FIGURE 2 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION
  • 1.4 INCLUSIONS & EXCLUSIONS
  • 1.5 YEARS CONSIDERED
  • 1.6 CURRENCY CONSIDERED
    • TABLE 1 US DOLLAR EXCHANGE RATES CONSIDERED, 2013-2018
  • 1.7 UNIT CONSIDERED
  • 1.8 STAKEHOLDERS
  • 1.9 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 3 NUTRACEUTICAL INGREDIENTS: RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key industry insights
      • 2.1.2.2 Breakdown of primary interviews
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 BOTTOM-UP
    • FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
    • 2.2.2 TOP-DOWN
    • FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
    • 2.2.3 SUPPLY-SIDE
    • FIGURE 7 DATA TRIANGULATION: SUPPLY-SIDE
    • 2.2.4 DEMAND-SIDE
    • FIGURE 8 DATA TRIANGULATION: DEMAND-SIDE
  • 2.3 DATA TRIANGULATION
    • FIGURE 9 DATA TRIANGULATION
  • 2.4 RESEARCH ASSUMPTIONS & LIMITATIONS
    • 2.4.1 ASSUMPTIONS
  • 2.5 RESEARCH LIMITATIONS & ASSOCIATED RISKS

3 EXECUTIVE SUMMARY

    • TABLE 2 NUTRACEUTICAL INGREDIENTS MARKET SNAPSHOT, 2022 VS. 2027
    • FIGURE 10 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022 VS. 2027 (USD BILLION)
    • FIGURE 11 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022 VS. 2027 (USD BILLION)
    • FIGURE 12 NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2022 VS. 2027 (USD BILLION)
    • FIGURE 13 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION

4 PREMIUM INSIGHTS

  • 4.1 ATTRACTIVE OPPORTUNITIES IN NUTRACEUTICAL INGREDIENTS MARKET
    • FIGURE 14 INCREASED CONSUMPTION OF FORTIFIED FOODS DUE TO GROWING HEALTH CONSCIOUSNESS AMONG CONSUMERS
  • 4.2 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY KEY TYPE AND COUNTRY
    • FIGURE 15 INDIA AND PROBIOTICS ACCOUNTED FOR LARGEST SHARES, BY COUNTRY AND TYPE, RESPECTIVELY
  • 4.3 NUTRACEUTICAL INGREDIENTS MARKET: REGIONAL SUBMARKETS
    • FIGURE 16 JAPAN TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
  • 4.4 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE AND REGION
    • FIGURE 17 ASIA PACIFIC TO DOMINATE NUTRACEUTICAL INGREDIENTS MARKET ACROSS ALL TYPES
  • 4.5 NUTRACEUTICAL INGREDIENTS MARKET, BY FORM
    • FIGURE 18 DRY SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • 4.6 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION
    • FIGURE 19 DIETARY SUPPLEMENTS SEGMENT TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MACROECONOMIC INDICATORS
    • 5.2.1 GLOBAL POPULATION WITNESSING HIGH PREVALENCE OF OBESITY
    • 5.2.2 KEY FACTS
      • 5.2.2.1 Aging population becoming more aware of benefits of nutraceuticals
    • FIGURE 20 US POPULATION AGED 65 AND OLDER, 2000-2060 (MILLION)
    • FIGURE 21 AGING POPULATION IN JAPAN, 2014-2018
  • 5.3 MARKET DYNAMICS
    • FIGURE 22 NUTRACEUTICAL INGREDIENTS: MARKET DYNAMICS
    • 5.3.1 DRIVERS
      • 5.3.1.1 Growing demand for fortified food due to increased health consciousness among consumers
    • FIGURE 23 CONSUMERS' PERCEPTION REGARDING WHAT TO CONSUME OR AVOID
      • 5.3.1.2 Increase in incidences of chronic diseases
    • FIGURE 24 PERCENTAGE OF US POPULATION WITH MULTIPLE CHRONIC ILLNESSES, 2017
    • FIGURE 25 CHRONIC DISEASES MOST PREVALENT WORLDWIDE AMONGST ALL AGES, 2019
    • FIGURE 26 NUMBER OF AMERICANS WITH CHRONIC CONDITIONS
      • 5.3.1.3 Mandates on food fortification by government organizations
    • TABLE 3 PREVALENCE OF THREE MAJOR MICRONUTRIENT DEFICIENCIES, BY REGION
    • TABLE 4 WIDELY USED FORTIFIED FOODS
    • FIGURE 27 NUMBER OF COUNTRIES WITH MANDATORY OR VOLUNTARY FOOD FORTIFICATION, 2021
    • 5.3.2 RESTRAINTS
      • 5.3.2.1 Higher costs of fortified products dissuade large-scale usage and adoption
    • 5.3.3 OPPORTUNITIES
      • 5.3.3.1 Innovations in nutraceutical ingredients industry
      • 5.3.3.2 Consumer awareness of micronutrient deficiencies
    • TABLE 5 FOODS TO BOOST IMMUNE SYSTEM
    • TABLE 6 MICRONUTRIENTS DEFICIENCY CONDITIONS AND THEIR WORLDWIDE PREVALENCE
    • 5.3.4 CHALLENGES
      • 5.3.4.1 Consumer skepticism associated with nutraceutical products

6 INDUSTRY TRENDS

  • 6.1 INTRODUCTION
  • 6.2 VALUE CHAIN ANALYSIS
    • FIGURE 28 VALUE CHAIN: NUTRACEUTICAL INGREDIENTS MARKET
    • 6.2.1 SOURCING OF RAW MATERIALS
    • 6.2.2 MANUFACTURING
    • 6.2.3 DISTRIBUTION, MARKETING, AND SALES
  • 6.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
    • FIGURE 29 REVENUE SHIFT FOR NUTRACEUTICAL INGREDIENTS MARKET
  • 6.4 TECHNOLOGY ANALYSIS
    • 6.4.1 FOOD MICROENCAPSULATION
      • 6.4.1.1 Encapsulation of omega-3 to mask the odor
    • 6.4.2 INNOVATIVE AND DISRUPTIVE TECH
      • 6.4.2.1 Robotics leading to innovations in market
      • 6.4.2.2 3D printing to uplift dietary supplements market
      • 6.4.2.3 Hologram Sciences-platform for personalized nutrition and advice
  • 6.5 PRICING ANALYSIS
    • FIGURE 30 PRICING ANALYSIS, 2017-2022 (USD/KG)
  • 6.6 PATENT ANALYSIS
    • FIGURE 31 PATENTS GRANTED FOR NUTRACEUTICAL INGREDIENTS MARKET, 2011-2021
    • FIGURE 32 REGIONAL ANALYSIS OF PATENTS GRANTED FOR NUTRACEUTICAL INGREDIENTS MARKET, 2011-2021
    • TABLE 7 KEY PATENTS PERTAINING NUTRACEUTICAL INGREDIENTS MARKET, 2021
  • 6.7 MARKET MAP
    • 6.7.1 UPSTREAM
      • 6.7.1.1 Ingredient Manufacturers
      • 6.7.1.2 Technology Providers
      • 6.7.1.3 Start-ups/Emerging Companies
    • 6.7.2 DOWNSTREAM
      • 6.7.2.1 Regulatory Bodies
      • 6.7.2.2 End Users
    • FIGURE 33 NUTRACEUTICALS INGREDIENTS MARKET MAP
    • TABLE 8 NUTRACEUTICAL INGREDIENTS MARKET: ECOSYSTEM
  • 6.8 TRADE SCENARIO
    • FIGURE 34 VITAMINS: IMPORT VALUE, BY KEY COUNTRY, 2017-2021 (USD THOUSAND)
    • TABLE 9 IMPORT DATA OF VITAMINS FOR KEY COUNTRIES, 2021 (VALUE)
    • FIGURE 35 VITAMINS: EXPORT VALUE, BY KEY COUNTRY, 2017-2021 (USD THOUSAND)
    • TABLE 10 EXPORT DATA ON VITAMINS FOR KEY COUNTRIES, 2021 (VALUE)
    • FIGURE 36 AMINO ACIDS: IMPORT VALUE, BY KEY COUNTRY, 2017-2021 (USD THOUSAND)
    • TABLE 11 IMPORT DATA ON AMINO ACIDS FOR KEY COUNTRIES, 2021 (VALUE)
    • FIGURE 37 AMINO ACIDS: EXPORT VALUE, BY KEY COUNTRY, 2017-2021 (USD THOUSAND)
    • TABLE 12 EXPORT DATA ON AMINO ACIDS FOR KEY COUNTRIES, 2021 (VALUE)
  • 6.9 KEY CONFERENCES & EVENTS IN 2022-2023
    • TABLE 13 NUTRACEUTICAL INGREDIENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2022-2023
  • 6.10 TARIFF AND REGULATORY LANDSCAPE
    • 6.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 14 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 15 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 16 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 17 SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 18 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 6.10.2 REGULATORY FRAMEWORK
      • 6.10.2.1 Organizations/Regulations governing nutraceutical ingredients market
    • TABLE 19 DEFINITIONS & REGULATIONS FOR NUTRACEUTICAL INGREDIENTS WORLDWIDE
      • 6.10.2.2 North America
        • 6.10.2.2.1 Canada
        • 6.10.2.2.2 US
        • 6.10.2.2.3 Mexico
      • 6.10.2.3 European Union (EU)
      • 6.10.2.4 Asia Pacific
        • 6.10.2.4.1 Japan
        • 6.10.2.4.2 China
        • 6.10.2.4.3 India
        • 6.10.2.4.4 Australia & New Zealand
      • 6.10.2.5 Rest of the World (RoW)
        • 6.10.2.5.1 Israel
        • 6.10.2.5.2 Brazil
      • 6.10.2.6 Probiotics
        • 6.10.2.6.1 Introduction
        • 6.10.2.6.2 National/International bodies for safety standards and regulations
    • TABLE 20 DEFINITIONS & REGULATIONS FOR NUTRACEUTICALS WORLDWIDE
        • 6.10.2.6.3 Codex Alimentarius Commission (CAC)
        • 6.10.2.6.4 North America: Regulatory environment analysis
        • 6.10.2.6.5 Europe: Regulatory environment analysis
        • 6.10.2.6.6 Asia Pacific: Regulatory environment analysis
        • 6.10.2.6.7 South America: Regulatory environment analysis
      • 6.10.2.7 Prebiotics
        • 6.10.2.7.1 Introduction
        • 6.10.2.7.2 Asia Pacific
    • TABLE 21 SCHEDULE - XI OF FOOD SAFETY AND STANDARDS REGULATIONS FOR LIST OF APPROVED PREBIOTIC INGREDIENTS, 2015
        • 6.10.2.7.3 North America
    • TABLE 22 LIST OF ACCEPTED DIETARY FIBERS BY CANADIAN REGULATORY AUTHORITIES & THEIR SOURCES
        • 6.10.2.7.4 European Union
  • 6.11 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 23 NUTRACEUTICAL INGREDIENTS MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 6.11.1 DEGREE OF COMPETITION
    • 6.11.2 BARGAINING POWER OF SUPPLIERS
    • 6.11.3 BARGAINING POWER OF BUYERS
    • 6.11.4 THREAT OF SUBSTITUTES
    • 6.11.5 THREAT OF NEW ENTRANTS
  • 6.12 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 6.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 38 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TYPES
    • TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TYPES (%)
    • 6.12.2 BUYING CRITERIA
    • TABLE 25 KEY CRITERIA FOR SELECTING SUPPLIER/VENDOR
    • FIGURE 39 KEY CRITERIA FOR SELECTING SUPPLIER/VENDOR
  • 6.13 CASE STUDY ANALYSIS
    • 6.13.1 FRUNUTTA STARTED OFFERING EASY-TO-USE AND EFFICIENT-TO-TAKE VITAMIN AND MINERAL PILLS THAT DISSOLVE INSTANTLY
    • 6.13.2 MINDRIGHT'S BARS HELP COMBAT MENTAL HEALTH ISSUES

7 NUTRACEUTICAL INGREDIENTS MARKET, BY HEALTH BENEFITS

  • 7.1 INTRODUCTION
  • 7.2 COGNITIVE HEALTH
  • 7.3 GUT HEALTH
  • 7.4 HEART HEALTH
  • 7.5 BONE HEALTH
    • TABLE 26 BONE-BUILDING NUTRIENTS & THEIR THERAPEUTIC RANGE
  • 7.6 IMMUNITY
  • 7.7 NUTRITION
  • 7.8 WEIGHT MANAGEMENT
  • 7.9 OTHERS

8 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE

  • 8.1 INTRODUCTION
    • FIGURE 40 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022 VS. 2027 (BY VALUE)
    • TABLE 27 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 28 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022-2027 (USD MILLION)
    • TABLE 29 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2021 (KT)
    • TABLE 30 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022-2027 (KT)
  • 8.2 PROBIOTIC
    • 8.2.1 HIGH DEMAND FOR SCIENTIFICALLY PROVEN HEALTH FOODS AND DIETARY SUPPLEMENTS
    • TABLE 31 PROBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017-2021 (USD MILLION)
    • TABLE 32 PROBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2027 (USD MILLION)
    • TABLE 33 PROBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017-2021 (KT)
    • TABLE 34 PROBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2027 (KT)
  • 8.3 PROTEINS & AMINO ACIDS
    • 8.3.1 IMPORTANT INGREDIENTS IN FOOD AND FEED INDUSTRIES
    • TABLE 35 PROTEINS & AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017-2021 (USD MILLION)
    • TABLE 36 PROTEINS & AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2027 (USD MILLION)
    • TABLE 37 PROTEINS & AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017-2021 (KT)
    • TABLE 38 PROTEINS & AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2027 (KT)
  • 8.4 PHYTOCHEMICALS & PLANT EXTRACTS
    • 8.4.1 GROWING DEMAND FOR ORGANIC FOOD PRODUCTS AND INGREDIENTS
    • TABLE 39 SPECIFIC PHYTOCHEMICALS AND THEIR POTENTIAL BENEFITS
    • TABLE 40 PHYTOCHEMICALS & PLANT EXTRACTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017-2021 (USD MILLION)
    • TABLE 41 PHYTOCHEMICALS & PLANT EXTRACTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2027 (USD MILLION)
    • TABLE 42 PHYTOCHEMICALS & PLANT EXTRACTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017-2021 (KT)
    • TABLE 43 PHYTOCHEMICALS & PLANT EXTRACTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2027 (KT)
  • 8.5 FIBERS & SPECIALTY CARBOHYDRATES
    • 8.5.1 ADDED TO FUNCTIONAL FOOD & BEVERAGES MORE FREQUENTLY
    • TABLE 44 FIBERS & SPECIALTY CARBOHYDRATES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017-2021 (USD MILLION)
    • TABLE 45 FIBERS & SPECIALTY CARBOHYDRATES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2027 (USD MILLION)
    • TABLE 46 FIBERS & SPECIALTY CARBOHYDRATES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017-2021 (KT)
    • TABLE 47 FIBERS & SPECIALTY CARBOHYDRATES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2027 (KT)
  • 8.6 OMEGA-3 FATTY ACIDS
    • 8.6.1 INCREASED USE OF OMEGA-3 TO ENHANCE HEART AND BRAIN HEALTH
    • TABLE 48 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017-2021 (USD MILLION)
    • TABLE 49 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2027 (USD MILLION)
    • TABLE 50 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017-2021 (KT)
    • TABLE 51 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2027 (KT)
  • 8.7 VITAMINS
    • 8.7.1 AWARENESS, WIDE ACCEPTANCE, AND EASY AVAILABILITY DRIVE DEMAND
    • TABLE 52 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017-2021 (USD MILLION)
    • TABLE 53 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2027 (USD MILLION)
    • TABLE 54 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017-2021 (KT)
    • TABLE 55 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2027 (KT)
  • 8.8 PREBIOTICS
    • 8.8.1 USED AS TEXTURE ENHANCEMENT AND SWEETENING AGENTS
    • TABLE 56 PREBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017-2021 (USD MILLION)
    • TABLE 57 PREBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2027 (USD MILLION)
    • TABLE 58 PREBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017-2021 (KT)
    • TABLE 59 PREBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2027 (KT)
  • 8.9 CAROTENOIDS
    • 8.9.1 GROWING FOOD ADDITIVES AND PERSONAL CARE INDUSTRIES TO PROPEL DEMAND
    • TABLE 60 SOURCES OF CAROTENOIDS IN FRUIT AND VEGETABLES AND THEIR MEDICINAL PROPERTIES
    • TABLE 61 CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017-2021 (USD MILLION)
    • TABLE 62 CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2027 (USD MILLION)
    • TABLE 63 CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017-2021 (KT)
    • TABLE 64 CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2027 (KT)
  • 8.10 MINERALS
    • 8.10.1 SEVERAL HEALTH ADVANTAGES ASSOCIATED WITH MINERALS
    • TABLE 65 MACROMINERALS & THEIR FUNCTIONS
    • TABLE 66 MICROMINERALS & THEIR FUNCTIONS
    • TABLE 67 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017-2021 (USD MILLION)
    • TABLE 68 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2027 (USD MILLION)
    • TABLE 69 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017-2021 (KT)
    • TABLE 70 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2027 (KT)
  • 8.11 OTHER TYPES
    • TABLE 71 OTHER TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017-2021 (USD MILLION)
    • TABLE 72 OTHER TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2027 (USD MILLION)
    • TABLE 73 OTHER TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017-2021 (KT)
    • TABLE 74 OTHER TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2027 (KT)

9 NUTRACEUTICAL INGREDIENTS MARKET, BY FORM

  • 9.1 INTRODUCTION
    • FIGURE 41 NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2022 VS. 2027 (BY VALUE)
    • TABLE 75 NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2017-2021 (USD MILLION)
    • TABLE 76 NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2022-2027 (USD MILLION)
  • 9.2 DRY
    • 9.2.1 BETTER STABILITY AND EASE OF HANDLING
    • TABLE 77 DRY: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017-2021 (USD MILLION)
    • TABLE 78 DRY: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2027 (USD MILLION)
  • 9.3 LIQUID
    • 9.3.1 LIMITED APPLICATIONS COMPARED TO DRY FORM
    • TABLE 79 LIQUID: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017-2021 (USD MILLION)
    • TABLE 80 LIQUID: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2027 (USD MILLION)

10 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION

  • 10.1 INTRODUCTION
    • FIGURE 42 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022 VS. 2027 (VALUE)
    • TABLE 81 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2017-2021 (USD MILLION)
    • TABLE 82 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022-2027 (USD MILLION)
  • 10.2 FOOD
    • TABLE 83 FOOD: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017-2021 (USD MILLION)
    • TABLE 84 FOOD: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2027 (USD MILLION)
    • 10.2.1 SNACKS
      • 10.2.1.1 Inclination toward protein-rich foods
    • 10.2.2 CONFECTIONERY
      • 10.2.2.1 Nutraceutical ingredients enhance texture, stability, and flavor
    • 10.2.3 BAKERY
      • 10.2.3.1 Adding omega-3 fatty acids lowers baking defects
    • 10.2.4 DAIRY
      • 10.2.4.1 Rising consumer awareness of health advantages of dairy products
    • 10.2.5 MEAT & MEAT PRODUCTS
      • 10.2.5.1 Major source of protein
    • 10.2.6 BABY FOOD
      • 10.2.6.1 High standards of living and preference for convenience foods
    • TABLE 85 RECOMMENDED DIETARY REFERENCE INTAKES (DRIS) FOR MACRONUTRIENTS
    • TABLE 86 RECOMMENDED DIETARY REFERENCE INTAKES (DRIS) FOR MICRONUTRIENTS
    • 10.2.7 OTHERS
    • FIGURE 43 GLOBALLY RISING IMPORTS AND EXPORTS OF CEREALS AND CEREAL PRODUCTS, 2016-2020
    • TABLE 87 FOOD: NUTRACEUTICAL INGREDIENTS MARKET, BY SUB-APPLICATION, 2017-2021 (USD MILLION)
    • TABLE 88 FOOD: NUTRACEUTICAL INGREDIENTS MARKET, BY SUB-APPLICATION, 2022-2027 (USD MILLION)
  • 10.3 BEVERAGES
    • TABLE 89 BEVERAGES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017-2021 (USD MILLION)
    • TABLE 90 BEVERAGES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2027 (USD MILLION)
    • 10.3.1 ENERGY DRINKS
      • 10.3.1.1 Offer specific medical and health benefits
    • 10.3.2 JUICES
      • 10.3.2.1 Functional benefits and growing health concerns
    • 10.3.3 HEALTH DRINKS
      • 10.3.3.1 Improves quality by reducing health risks
    • TABLE 91 NUTRACEUTICAL INGREDIENTS MARKET FOR BEVERAGES, BY SUB-APPLICATION, 2017-2021 (USD MILLION)
    • TABLE 92 NUTRACEUTICAL INGREDIENTS MARKET FOR BEVERAGES, BY SUB-APPLICATION, 2022-2027 (USD MILLION)
  • 10.4 PERSONAL CARE
    • 10.4.1 PREFERENCE FOR ORGANIC PERSONAL CARE PRODUCTS.
    • TABLE 93 PERSONAL CARE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017-2021 (USD MILLION)
    • TABLE 94 PERSONAL CARE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2027 (USD MILLION)
  • 10.5 ANIMAL NUTRITION
    • 10.5.1 RISING ANIMAL HEALTH AND NUTRITION MARKET
    • TABLE 95 ANIMAL NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017-2021 (USD MILLION)
    • TABLE 96 ANIMAL NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2027 (USD MILLION)
  • 10.6 DIETARY SUPPLEMENTS
    • 10.6.1 OFFER SEVERAL HEALTH BENEFITS
    • TABLE 97 DIETARY SUPPLEMENTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017-2021 (USD MILLION)
    • TABLE 98 DIETARY SUPPLEMENTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2027 (USD MILLION)

11 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION

  • 11.1 INTRODUCTION
    • TABLE 99 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017-2021 (USD MILLION)
    • TABLE 100 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2027 (USD MILLION)
    • FIGURE 44 REGIONAL SNAPSHOT: US ACQUIRED LARGEST SHARE IN NUTRACEUTICAL INGREDIENTS MARKET, 2021
  • 11.2 NORTH AMERICA
    • TABLE 101 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2017-2021 (USD MILLION)
    • TABLE 102 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2022-2027 (USD MILLION)
    • TABLE 103 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 104 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022-2027 (USD MILLION)
    • TABLE 105 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2017-2021 (USD MILLION)
    • TABLE 106 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022-2027 (USD MILLION)
    • TABLE 107 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2017-2021 (USD MILLION)
    • TABLE 108 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2022-2027 (USD MILLION)
    • 11.2.1 US
      • 11.2.1.1 Improved quality of livestock-based products amid increased consumer demand
    • TABLE 109 US: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 110 US: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022-2027 (USD MILLION)
    • 11.2.2 CANADA
      • 11.2.2.1 Increased government support for R&D
    • FIGURE 45 CANADA: OVERWEIGHT OR OBESE, BY AGE GROUP AND SEX, 2018
    • TABLE 111 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 112 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022-2027 (USD MILLION)
    • 11.2.3 MEXICO
      • 11.2.3.1 Growing health and wellness trends
    • FIGURE 46 MEXICO: PER CAPITA EXPENDITURE ON FOOD, 2010-2018
    • TABLE 113 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 114 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022-2027 (USD MILLION)
  • 11.3 EUROPE
    • TABLE 115 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2017-2021 (USD MILLION)
    • TABLE 116 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2022-2027 (USD MILLION)
    • TABLE 117 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 118 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022-2027 (USD MILLION)
    • TABLE 119 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2017-2021 (USD MILLION)
    • TABLE 120 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022-2027 (USD MILLION)
    • TABLE 121 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2017-2021 (USD MILLION)
    • TABLE 122 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2022-2027 (USD MILLION)
    • 11.3.1 GERMANY
      • 11.3.1.1 Multiple applications of nutraceuticals in food & beverages and personal care products.
    • TABLE 123 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 124 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022-2027 (USD MILLION)
    • 11.3.2 FRANCE
      • 11.3.2.1 Increased health awareness and strategic government initiatives
    • TABLE 125 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 126 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022-2027 (USD MILLION)
    • 11.3.3 UK
      • 11.3.3.1 High demand for nutraceutical ingredients from food & beverage industry
    • TABLE 127 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 128 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022-2027 (USD MILLION)
    • 11.3.4 ITALY
      • 11.3.4.1 Increased consumption of food supplements
    • TABLE 129 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 130 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022-2027 (USD MILLION)
    • 11.3.5 SPAIN
      • 11.3.5.1 Preference for functional food and beverages
    • TABLE 131 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 132 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022-2027 (USD MILLION)
    • 11.3.6 RUSSIA
      • 11.3.6.1 Complicated and expensive registration process
    • TABLE 133 RUSSIA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 134 RUSSIA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022-2027 (USD MILLION)
    • 11.3.7 REST OF EUROPE
    • TABLE 135 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 136 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022-2027 (USD MILLION)
  • 11.4 ASIA PACIFIC
    • FIGURE 47 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, 2021
    • TABLE 137 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2017-2021 (USD MILLION)
    • TABLE 138 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2022-2027 (USD MILLION)
    • TABLE 139 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 140 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022-2027 (USD MILLION)
    • TABLE 141 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2017-2021 (USD MILLION)
    • TABLE 142 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022-2027 (USD MILLION)
    • TABLE 143 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2017-2021 (USD MILLION)
    • TABLE 144 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2022-2027 (USD MILLION)
    • 11.4.1 CHINA
      • 11.4.1.1 Changing lifestyles of consumers
    • TABLE 145 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 146 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022-2027 (USD MILLION)
    • 11.4.2 JAPAN
      • 11.4.2.1 Preference for fortified foods over conventional ones
    • TABLE 147 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 148 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022-2027 (USD MILLION)
    • 11.4.3 INDIA
      • 11.4.3.1 High consumer demand due to rising hospitalization costs
    • TABLE 149 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 150 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022-2027 (USD MILLION)
    • 11.4.4 AUSTRALIA & NEW ZEALAND
      • 11.4.4.1 Preference for low-calorie foods to prevent chronic conditions
    • TABLE 151 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 152 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022-2027 (USD MILLION)
    • 11.4.5 REST OF ASIA PACIFIC
    • TABLE 153 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 154 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022-2027 (USD MILLION)
  • 11.5 SOUTH AMERICA
    • TABLE 155 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2017-2021 (USD MILLION)
    • TABLE 156 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2022-2027 (USD MILLION)
    • TABLE 157 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 158 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022-2027 (USD MILLION)
    • TABLE 159 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2017-2021 (USD MILLION)
    • TABLE 160 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022-2027 (USD MILLION)
    • TABLE 161 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2017-2021 (USD MILLION)
    • TABLE 162 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2022-2027 (USD MILLION)
    • 11.5.1 BRAZIL
      • 11.5.1.1 Rising health consciousness and rapid urbanization
    • TABLE 163 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 164 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022-2027 (USD MILLION)
    • 11.5.2 ARGENTINA
      • 11.5.2.1 Affinity toward healthy foods and functional beverages
    • FIGURE 48 PREVALENCE OF UNDERNOURISHMENT IN ARGENTINA, 2012-2019
    • TABLE 165 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 166 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022-2027 (USD MILLION)
    • 11.5.3 REST OF SOUTH AMERICA
    • TABLE 167 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 168 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022-2027 (USD MILLION)
  • 11.6 REST OF THE WORLD (ROW)
    • TABLE 169 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017-2021 (USD MILLION)
    • TABLE 170 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2027 (USD MILLION)
    • TABLE 171 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 172 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022-2027 (USD MILLION)
    • TABLE 173 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2017-2021 (USD MILLION)
    • TABLE 174 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022-2027 (USD MILLION)
    • TABLE 175 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2017-2021 (USD MILLION)
    • TABLE 176 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2022-2027 (USD MILLION)
    • 11.6.1 MIDDLE EAST
      • 11.6.1.1 Increased demand for healthy foods amid rising health concerns
    • TABLE 177 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 178 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022-2027 (USD MILLION)
    • 11.6.2 AFRICA
      • 11.6.2.1 Government initiatives for fortification of food with essential vitamins and minerals
    • TABLE 179 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 180 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022-2027 (USD MILLION)

12 COMPETITIVE LANDSCAPE

  • 12.1 OVERVIEW
  • 12.2 MARKET SHARE ANALYSIS, 2021
    • TABLE 181 NUTRACEUTICAL INGREDIENTS MARKET: DEGREE OF COMPETITION (COMPETITIVE)
  • 12.3 SEGMENTAL REVENUE ANALYSIS OF KEY PLAYERS
    • FIGURE 49 SEGMENTAL REVENUE ANALYSIS OF KEY MARKET PLAYERS, 2017-2021 (USD BILLION)
  • 12.4 STRATEGIES ADOPTED BY KEY PLAYERS
  • 12.5 COMPANY EVALUATION QUADRANT (KEY PLAYERS)
    • 12.5.1 STARS
    • 12.5.2 EMERGING LEADERS
    • 12.5.3 PERVASIVE PLAYERS
    • 12.5.4 PARTICIPANTS
    • FIGURE 50 NUTRACEUTICAL INGREDIENTS MARKET: COMPANY EVALUATION QUADRANT, 2021 (KEY PLAYERS)
    • 12.5.5 PRODUCT FOOTPRINT
    • TABLE 182 COMPANY FOOTPRINT, BY TYPE
    • TABLE 183 COMPANY FOOTPRINT, BY APPLICATION
    • TABLE 184 COMPANY FOOTPRINT, BY REGION
    • TABLE 185 OVERALL COMPANY FOOTPRINT
  • 12.6 NUTRACEUTICAL INGREDIENTS MARKET: EVALUATION QUADRANT FOR START-UPS/SMES, 2021
    • 12.6.1 PROGRESSIVE COMPANIES
    • 12.6.2 STARTING BLOCKS
    • 12.6.3 RESPONSIVE COMPANIES
    • 12.6.4 DYNAMIC COMPANIES
    • FIGURE 51 NUTRACEUTICAL INGREDIENTS MARKET: COMPANY EVALUATION QUADRANT, 2021 (START-UPS/SME)
    • 12.6.5 COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES
    • TABLE 186 NUTRACEUTICAL INGREDIENTS MARKET: DETAILED LIST OF KEY START-UPS/SMES
    • TABLE 187 NUTRACEUTICAL INGREDIENTS MARKET: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES
  • 12.7 PRODUCT LAUNCHES, DEALS, AND OTHER DEVELOPMENTS
    • 12.7.1 PRODUCT LAUNCHES
    • TABLE 188 NUTRACEUTICAL INGREDIENTS: PRODUCT LAUNCHES, 2018-2022
    • 12.7.2 DEALS
    • TABLE 189 NUTRACEUTICAL INGREDIENTS: DEALS, 2018-2022
    • 12.7.3 OTHERS
    • TABLE 190 NUTRACEUTICAL INGREDIENTS: OTHERS, 2019-2022

13 COMPANY PROFILES

(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**

  • 13.1 INTRODUCTION
  • 13.2 KEY PLAYERS
    • 13.2.1 ASSOCIATED BRITISH FOODS PLC
    • TABLE 191 ASSOCIATED BRITISH FOODS PLC: BUSINESS OVERVIEW
    • FIGURE 52 ASSOCIATED BRITISH FOODS PLC: COMPANY SNAPSHOT
    • TABLE 192 ASSOCIATED BRITISH FOODS PLC: PRODUCTS OFFERED
    • 13.2.2 ARLA FOODS AMBA
    • TABLE 193 ARLA FOODS AMBA: BUSINESS OVERVIEW
    • FIGURE 53 ARLA FOODS AMBA: COMPANY SNAPSHOT
    • TABLE 194 ARLA FOODS AMBA: PRODUCTS OFFERED
    • 13.2.3 DSM
    • TABLE 195 DSM: BUSINESS OVERVIEW
    • FIGURE 54 DSM: COMPANY SNAPSHOT
    • TABLE 196 DSM: PRODUCTS OFFERED
    • TABLE 197 DSM: DEALS
    • 13.2.4 INGREDION
    • TABLE 198 INGREDION: BUSINESS OVERVIEW
    • FIGURE 55 INGREDION: COMPANY SNAPSHOT
    • TABLE 199 INGREDION: PRODUCTS OFFERED
    • TABLE 200 INGREDION: PRODUCT LAUNCHES
    • TABLE 201 INGREDION: DEALS
    • TABLE 202 INGREDION: OTHERS
    • 13.2.5 TATE & LYLE
    • TABLE 203 TATE & LYLE: BUSINESS OVERVIEW
    • FIGURE 56 TATE & LYLE: COMPANY SNAPSHOT
    • TABLE 204 TATE & LYLE: PRODUCTS OFFERED
    • TABLE 205 TATE & LYLE: PRODUCT LAUNCHES
    • TABLE 206 TATE & LYLE: DEALS
    • TABLE 207 TATE & LYLE: OTHERS
    • 13.2.6 AJINOMOTO CO., INC.
    • TABLE 208 AJINOMOTO CO., INC.: BUSINESS OVERVIEW
    • FIGURE 57 AJINOMOTO CO., INC.: COMPANY SNAPSHOT
    • TABLE 209 AJINOMOTO CO., INC.: PRODUCTS OFFERED
    • TABLE 210 AJINOMOTO CO., INC.: DEALS
    • TABLE 211 AJINOMOTO CO., INC.: OTHERS
    • 13.2.7 CHR HANSEN HOLDING A/S.
    • TABLE 212 CHR HANSEN HOLDING A/S. BUSINESS OVERVIEW
    • FIGURE 58 CHR HANSEN HOLDING A/S. COMPANY SNAPSHOT
    • TABLE 213 CHR HANSEN HOLDING A/S. PRODUCTS OFFERED
    • TABLE 214 CHR HANSEN HOLDING A/S. PRODUCT LAUNCHES
    • TABLE 215 CHR HANSEN HOLDING A/S. DEALS
    • TABLE 216 CHR HANSEN HOLDING A/S: OTHERS
    • 13.2.8 KYOWA HAKKO BIO CO., LTD.
    • TABLE 217 KYOWA HAKKO BIO CO., LTD.: BUSINESS OVERVIEW
    • FIGURE 59 KYOWA HAKKO BIO CO., LTD.: COMPANY SNAPSHOT
    • TABLE 218 KYOWA HAKKO BIO CO., LTD.: PRODUCTS OFFERED
    • 13.2.9 GLANBIA PLC
    • TABLE 219 GLANBIA PLC: BUSINESS OVERVIEW
    • FIGURE 60 GLANBIA PLC: COMPANY SNAPSHOT
    • TABLE 220 GLANBIA PLC: PRODUCTS OFFERED
    • TABLE 221 GLANBIA PLC: PRODUCT LAUNCHES
    • TABLE 222 GLANBIA PLC: DEALS
    • TABLE 223 GLANBIA PLC: OTHERS
    • 13.2.10 FONTERRA CO-OPERATIVE GROUP LIMITED
    • TABLE 224 FONTERRA CO.-OPERATIVE GROUP LIMITED: BUSINESS OVERVIEW
    • FIGURE 61 FONTERRA CO.-OPERATIVE GROUP LIMITED: COMPANY SNAPSHOT
    • TABLE 225 FONTERRA CO. OPERATIVE GROUP LIMITED: PRODUCTS OFFERED
    • TABLE 226 FONTERRA CO.-OPERATIVE GROUP LIMITED: DEALS
    • 13.2.11 CARGILL INCORPORATED
    • TABLE 227 CARGILL INCORPORATED: BUSINESS OVERVIEW
    • FIGURE 62 CARGILL INCORPORATED: COMPANY SNAPSHOT
    • TABLE 228 CARGILL INCORPORATED: PRODUCTS OFFERED
    • TABLE 229 CARGILL INCORPORATED: PRODUCT LAUNCHES
    • TABLE 230 CARGILL INCORPORATED: DEALS
    • TABLE 231 CARGILL INCORPORATED: OTHERS
    • 13.2.12 ADM
    • TABLE 232 ADM: BUSINESS OVERVIEW
    • FIGURE 63 ADM: COMPANY SNAPSHOT
    • TABLE 233 ADM: PRODUCTS OFFERED
    • TABLE 234 ADM: PRODUCT LAUNCHES
    • TABLE 235 ADM: DEALS
    • TABLE 236 ADM: OTHERS
    • 13.2.13 INTERNATIONAL FLAVORS & FRAGRANCES INC.
    • TABLE 237 INTERNATIONAL FLAVORS & FRAGRANCES INC.: BUSINESS OVERVIEW
    • FIGURE 64 INTERNATIONAL FLAVORS & FRAGRANCES INC.: COMPANY SNAPSHOT
    • TABLE 238 INTERNATIONAL FLAVORS & FRAGRANCES INC.: PRODUCTS OFFERED
    • TABLE 239 INTERNATIONAL FLAVORS & FRAGRANCES INC.: PRODUCT LAUNCHES
    • TABLE 240 INTERNATIONAL FLAVORS & FRAGRANCES INC.: DEALS
    • TABLE 241 INTERNATIONAL FLAVORS & FRAGRANCES INC.: OTHERS
    • 13.2.14 BASF SE
    • TABLE 242 BASF SE: BUSINESS OVERVIEW
    • FIGURE 65 BASF SE: COMPANY SNAPSHOT
    • TABLE 243 BASF SE: PRODUCTS OFFERED
    • TABLE 244 BASF SE: OTHERS
    • 13.2.15 KERRY GROUP PLC
    • TABLE 245 KERRY GROUP PLC: BUSINESS OVERVIEW
    • FIGURE 66 KERRY GROUP PLC: COMPANY SNAPSHOT
    • TABLE 246 KERRY GROUP PLC: PRODUCTS OFFERED
    • TABLE 247 KERRY GROUP PLC: PRODUCT LAUNCHES
    • TABLE 248 KERRY GROUP PLC: DEALS
    • TABLE 249 KERRY GROUP PLC: OTHERS
  • 13.3 OTHER PLAYERS
    • 13.3.1 BALCHEM INC.
    • 13.3.2 SYDLER INDIA PVT. LTD.
    • 13.3.3 PROBI
    • 13.3.4 DIVI'S LABORATORIES LIMITED
    • 13.3.5 MARTIN BAUER
    • 13.3.6 BENEO GMBH
    • 13.3.7 NEXIRA
    • 13.3.8 ROQUETTE FRERES
    • 13.3.9 CONAGEN, INC.
    • 13.3.10 NUTRACEUTICALS GROUPS
  • *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

14 ADJACENT & RELATED MARKETS

  • 14.1 INTRODUCTION
  • 14.2 LIMITATIONS
  • 14.3 FUNCTIONAL FOOD INGREDIENTS MARKET
    • 14.3.1 MARKET DEFINITION
    • 14.3.2 MARKET OVERVIEW
    • 14.3.3 FUNCTIONAL FOOD INGREDIENTS MARKET, BY TYPE
      • 14.3.3.1 Introduction
    • TABLE 250 FUNCTIONAL FOOD INGREDIENTS MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 251 FUNCTIONAL FOOD INGREDIENTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • 14.3.4 FUNCTIONAL FOOD INGREDIENTS MARKET, BY REGION
      • 14.3.4.1 Introduction
    • TABLE 252 FUNCTIONAL FOOD INGREDIENTS MARKET, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 253 FUNCTIONAL FOOD INGREDIENTS MARKET, BY REGION, 2021-2026 (USD MILLION)
  • 14.4 NUTRACEUTICAL EXCIPIENTS MARKET
    • 14.4.1 MARKET DEFINITION
    • 14.4.2 MARKET OVERVIEW
    • 14.4.3 NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT
      • 14.4.3.1 Introduction
    • TABLE 254 NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 255 NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2018-2025 (KT)
    • 14.4.4 NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION
      • 14.4.4.1 Introduction
    • TABLE 256 NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 257 NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018-2025 (KT)

15 APPENDIX

  • 15.1 DISCUSSION GUIDE
  • 15.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 15.3 CUSTOMIZATION OPTIONS
  • 15.4 RELATED REPORTS
  • 15.5 AUTHOR DETAILS